Keyphrases
Routine Care
100%
Atrial Fibrillation
100%
Concomitant Drugs
100%
Direct Oral Anticoagulants
100%
Vitamin K Antagonists
69%
Major Bleeding
46%
Polypharmacy
30%
Confidence Interval
23%
Hazard Ratio
23%
Mortality Risk
15%
Ischemic Stroke
15%
Bleeding
15%
Non-majors
15%
All-cause Mortality
7%
Randomized Controlled Trial
7%
Relative Risk
7%
General Practice
7%
Effect Modification
7%
Interaction Terms
7%
United Kingdom
7%
Stroke Risk
7%
Clinical Practice Research Datalink
7%
Bleeding Risk
7%
Apixaban
7%
Concomitant Drug Use
7%
Clinical Analysis
7%
Non-valvular Atrial Fibrillation
7%
Cox Proportional Hazards Regression
7%
Patient Risk
7%
Population-wide
7%
Medicine and Dentistry
Patient Care
100%
Atrial Fibrillation
100%
Direct Oral Anticoagulant
100%
Concomitant Drug
100%
Vitamin K Antagonist
69%
Major Bleeding
46%
Polypharmacy
30%
Hazard Ratio
23%
Bleeding
15%
Brain Ischemia
15%
All Cause Mortality
7%
Proportional Hazards Model
7%
General Medicine
7%
Apoplexy
7%
Drug Use
7%
Randomized Controlled Trial
7%
Apixaban
7%
Pharmacology, Toxicology and Pharmaceutical Science
Direct Oral Anticoagulant
100%
Concomitant Drug
100%
Atrial Fibrillation
100%
Antivitamin K
69%
Bleeding
61%
Polypharmacy
30%
Brain Ischemia
15%
Randomized Controlled Trial
7%
All Cause Mortality
7%
Apixaban
7%
Cerebrovascular Accident
7%